Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

47.3K
Overview
47.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Distinct Plasmodium falciparum Erythrocyte Membrane Protein 1 Domain Cassette-Associated Antibody Gaps Specific to Cerebral Malaria and Severe Malarial Anemia.

The Journal of infectious diseases·2026
Same author

Safety, Tolerability, and Pharmacokinetics of 6-Diazo-5-Oxo-L-Norleucine in Malawian Adults With and Without Malaria: A Phase 1 Dose-Escalation Clinical Trial.

The Journal of infectious diseases·2026
Same author

AGS-v PLUS, a Mosquito Salivary Peptide Vaccine, Modulates the Response to <i>Aedes</i> Mosquito Bites in Humans.

Vaccines·2025
Same author

Vaccine-Induced Antibodies to a C-Terminal Plasmodium falciparum Circumsporozoite Protein Epitope Associated With Protection Against Malaria Challenge.

The Journal of infectious diseases·2025
Same author

Computational Prioritization of T Cell Epitopes to Overcome HLA Restriction and Antigenic Diversity in <i>Plasmodium falciparum</i>.

bioRxiv : the preprint server for biology·2025
Same author

A shared inflammatory signature across severe malaria syndromes manifested by transcriptomic, proteomic and metabolomic analyses.

Nature communications·2025
Same journal

Safety and immunogenicity of a COVID-19-Influenza Combination nanoparticle vaccine (CIC) containing SARS-CoV-2 recombinant spike and quadrivalent influenza hemagglutinin with Matrix-M® adjuvant: A phase 1/2 clinical trial.

Human vaccines & immunotherapeutics·2026
Same journal

Randomized controlled trial evaluating immunogenicity and safety of a porcine circovirus-free rotavirus vaccine in healthy Chinese infants.

Human vaccines & immunotherapeutics·2026
Same journal

Determinants of HPV vaccination acceptance among young adult women in Japan's catch-up generation: A cross-sectional study.

Human vaccines & immunotherapeutics·2026
Same journal

Spatial accessibility analysis of vaccination units in Gansu Province, China (2025).

Human vaccines & immunotherapeutics·2026
Same journal

Pneumococcal vaccination awareness and uptake among high-risk patients attending internal medicine outpatient clinics: A cross-sectional study.

Human vaccines & immunotherapeutics·2026
Same journal

How vaccine research took me on an international journey.

Human vaccines & immunotherapeutics·2026
See all related articles

Related Experiment Video

Updated: Oct 25, 2025

In Vitro Assay of Plasmodium-Infected Red Blood Cell Killing by Cytotoxic Lymphocytes
08:20

In Vitro Assay of Plasmodium-Infected Red Blood Cell Killing by Cytotoxic Lymphocytes

Published on: August 17, 2022

2.3K

Novel malaria vaccines.

Matthew B Laurens1

  • 1Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, USA.

Human Vaccines & Immunotherapeutics
|August 4, 2021
PubMed
Summary
This summary is machine-generated.

Developing new malaria vaccines, including next-generation approaches and novel delivery systems, offers hope for sustained protection, especially for children most affected by malaria mortality.

Keywords:
Plasmodium falciparummalaria eliminationmalaria vaccine

More Related Videos

Ookluc: A Plasmodium berghei Line for Identifying Transmission-blocking Compounds
07:14

Ookluc: A Plasmodium berghei Line for Identifying Transmission-blocking Compounds

Published on: July 11, 2025

302
Generating Genetically Modified Plasmodium berghei Sporozoites
10:16

Generating Genetically Modified Plasmodium berghei Sporozoites

Published on: May 5, 2023

1.5K

Related Experiment Videos

Last Updated: Oct 25, 2025

In Vitro Assay of Plasmodium-Infected Red Blood Cell Killing by Cytotoxic Lymphocytes
08:20

In Vitro Assay of Plasmodium-Infected Red Blood Cell Killing by Cytotoxic Lymphocytes

Published on: August 17, 2022

2.3K
Ookluc: A Plasmodium berghei Line for Identifying Transmission-blocking Compounds
07:14

Ookluc: A Plasmodium berghei Line for Identifying Transmission-blocking Compounds

Published on: July 11, 2025

302
Generating Genetically Modified Plasmodium berghei Sporozoites
10:16

Generating Genetically Modified Plasmodium berghei Sporozoites

Published on: May 5, 2023

1.5K

Area of Science:

  • Vaccinology
  • Immunology
  • Infectious Diseases

Background:

  • Malaria remains a significant global health burden, particularly for children, necessitating effective interventions.
  • The RTS,S/AS01 malaria vaccine demonstrates moderate efficacy and is undergoing implementation studies.
  • Advancements in vaccine science are crucial for controlling malaria transmission and mortality.

Purpose of the Study:

  • To review the progress and future directions in malaria vaccine development.
  • To highlight novel strategies and delivery platforms for next-generation malaria vaccines.
  • To explore the potential application of technologies from other vaccine fields, such as COVID-19 vaccines, to malaria.

Main Methods:

  • Review of current malaria vaccine candidates and developmental strategies.
  • Exploration of novel vaccine delivery systems, including RNA and nanoparticle technologies.
  • Consideration of established and emerging vaccine development techniques.

Main Results:

  • RTS,S/AS01 malaria vaccine shows moderate efficacy and is in implementation studies.
  • Multiple next-generation malaria vaccine strategies are under active investigation.
  • Novel delivery approaches, inspired by other vaccine technologies, are being advanced.

Conclusions:

  • Highly effective malaria vaccines offering sustained protection are achievable through continued scientific advancement.
  • Next-generation vaccines and innovative delivery methods are critical for overcoming the malaria burden.
  • Leveraging knowledge from diverse vaccine development efforts can accelerate progress toward an effective malaria vaccine.